Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04738279 · ClinicalTrials.gov registry record · Phase 2
The CASCADE HF Soft Launch and Calibration Phase I and II
A Phase 2 study of Heart Failure, sponsored by Endeavor Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04738279 is a Phase 2 study of Heart Failure that has completed, run by Endeavor Health. The registered enrollment target is 20 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04738279, a Phase 2 study of Heart Failure, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Invasive telemonitoring has shown promising results in reducing readmissions and health service utilization, and improving patient outcomes; however, such evidence is lacking for non-invasive telemonitoring. Our proposal is to deploy a wearable solution that predicts physiological perturbation comparable to invasive devices and to perform continuous remote patient monitoring; this will be connected to a structured, cascading, escalation pathway involving home health nurses, advanced practitioner providers, specialists, and surgeons, and has the potential to transform care management in the post-discharge period, where patients are the most vulnerable for readmission.
Conditions Studied
Interventions
- OTHER Affective Analysis of Participant Response to Continuous Remote Patient Monitoring
- DEVICE Non-Invasive Continuous Remote Patient Monitoring
Study Locations (1)
Illinois
- NorthShore University HealthSystem Evanston Hospital - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2021-10-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04738279
The ClinicalTrials.gov registry entry for NCT04738279 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Affective Analysis of Participant Response to Continuous Remote Patient Monitoring is the first listed.
NCT04738279 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04738279 about?
NCT04738279 is a clinical study titled "The CASCADE HF Soft Launch and Calibration Phase I and II". Invasive telemonitoring has shown promising results in reducing readmissions and health service utilization, and improving patient outcomes; however, such evidence is lacking for non-invasive telemonitoring. Our proposal is to deploy a wearable solution that predicts physiological perturbation compa...
What is the current status of trial NCT04738279?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2020-12-14. Estimated completion is 2021-10-30.
What conditions does trial NCT04738279 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04738279?
The interventions under investigation include: Affective Analysis of Participant Response to Continuous Remote Patient Monitoring (OTHER), Non-Invasive Continuous Remote Patient Monitoring (DEVICE).
Who is sponsoring clinical trial NCT04738279?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04738279 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
RECRUITING · Phase 2
-
Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial
RECRUITING · Phase 2
-
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · Phase 2
-
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
RECRUITING · Phase 2
-
Metformin for Pulmonary Hypertension HFpEF
RECRUITING · Phase 2
-
The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.